Results 81 to 90 of about 15,400 (157)
BACKGROUND AND OBJECTIVES: The prothrombin G20210A mutation and factor V Leiden have been found to be associated with an increased risk of venous thrombosis, but the reported prevalences of the prothrombin gene variant both in the normal population and ...
J Aznar +9 more
doaj
Homozygous factor V leiden mutation: Rare etiology of pulmonary embolism. [PDF]
El Marraki Z +5 more
europepmc +1 more source
R Kreidy1, N Irani-Hakime21Department of Vascular Surgery, 2Department of Laboratory Medicine, Saint George Hospital, University Medical Center, University of Balamand, Beirut, LebanonAim: Factor V Leiden (R506Q) mutation is the most commonly ...
R Kreidy, N Irani-Hakime
doaj
Case report: Umbilical vessel aneurysm thrombosis and factor V Leiden mutation leading to fetal demise. [PDF]
Oualiken C +7 more
europepmc +1 more source
Right Ventricular Thrombus in a 36-Year-Old Man with Factor V Leiden
Factor V Leiden deficiency is the most common hereditary hypercoagulable disease in the United States and involves 5% of the Caucasian population. Up to 30% of patients who present with deep vein thrombosis (DVT) or pulmonary thromboembolism present with
Shokoufeh Hajsadeghi +3 more
doaj
The article is devoted to the prevalence of polymorphism of genes responsible for thrombophilia among children. The study included 52 children with thrombosis and 59 children without thrombosis. Detects mutations factor V Leiden, G20210A prothrombin gene,
L. V. Zhdanova +2 more
doaj
Successful Conservative Treatment of a Complicated Aortic Thrombus in a Woman with Factor V Leiden Mutation. [PDF]
Frebutte E +4 more
europepmc +1 more source
Patients with cancer have an increased risk for thromboembolism, which might be related to several factors including central venous catheters and chemotherapeutics.
Funda Corapçioğlu +5 more
doaj
The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey
Resistance to activated protein C (APC), which is caused by a single point mutation in the gene for factor V, is a common risk factor for thrombosis. In this study, we screened factor V (FV) Leiden mutation in 81 subjects.
A Gürgey, L Mesci
doaj
Current Knowledge on Factor V Leiden Mutation as a Risk Factor for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis. [PDF]
Eppenberger D +4 more
europepmc +1 more source

